How high-dose chemotherapy and stem cell transplants rescue patients with relapsed testicular cancer
In short: When standard chemotherapy fails to stop testicular cancer, doctors may turn to a high-stakes intervention. By using extremely high doses of chemotherapy followed by a stem cell transplant, clinicians can target aggressive, advanced disease, even when the cancer has spread to the brain.
Testicular cancer often presents in an early stage, confined to the testicle. However, it follows a predictable, stepwise pattern of spread. Because the testes originate in the abdominal area, the first site of spread is typically the abdominal lymph nodes, followed by the chest and, eventually, the brain. While many cases are cured with first-line chemotherapy, some patients experience recurrence or advanced disease that does not respond to standard treatments. Staging evaluations are typically performed to check for any presence of cancer elsewhere in the body. This process helps determine if the malignancy is confined to the testicle or has already begun to spread.
For these rare, advanced cases, doctors may use second-line therapy or very high-dose chemotherapy. While effective against cancer, high-dose chemotherapy can shut down the bone marrow, which is responsible for producing essential red and white blood cells. Without these cells, the body cannot carry oxygen or maintain an immune system. To prevent this, a bone marrow transplant—using the patient's own peripheral blood stem cells—is used to restore these critical functions. This procedure involves transplanting healthy, unaffected marrow to replace the damaged cells. This intervention is necessary because the patient's own marrow can no longer produce the blood components required for survival.
Research led by Lawrence Einhorn at Indiana University studied 364 patients who relapsed after initial chemotherapy between 2004 and 2014. The study, published in the Journal of Clinical Oncology, found that high-dose chemotherapy combined with a stem cell transplant cured 60 percent of men, even those with aggressive disease. This approach, which includes drugs like carboplatin and etoposide, was found to be well tolerated with low treatment-related mortality. The findings suggest that even patients with highly aggressive forms of the disease can see positive results. This treatment remains a viable option for those who did not respond to their initial chemotherapy courses.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Bone Marrow Transplant | Testicular Cancer
- Also: High-dose chemotherapy with stem cell transplant cures most relapsed testis cancer cases
- Also: www.nature.com — A blood stem cell transplant in a person with concomitant Hodgkin disease and testicular carcinoma | Bone Marrow Transplantation
To cite this card, link to https://intellectplus.co.uk/app/society-bone-marrow-transplant-testicular-cancer.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Society · Latest · A–Z · All topics